Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial (Q44953760)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial |
scientific article |
Statements
1 reference
Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial (English)
1 reference
1 reference
1 reference
1 reference
Pietro D Ragonesi
1 reference
Leonardina Ciccarelli
1 reference
Mario N Piccinni
1 reference
Antonio Gaddi
1 reference
Gianandrea Bertone
1 reference
1 reference
Identifiers
1 reference